Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,973
  • Shares Outstanding, K 118,513
  • Annual Sales, $ 7,730 K
  • Annual Income, $ -64,100 K
  • 60-Month Beta 1.88
  • Price/Sales 13.80
  • Price/Cash Flow N/A
  • Price/Book 1.49
Trade OCX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.47
  • Most Recent Earnings -0.11 on 05/11/22
  • Next Earnings Date 08/09/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 249.85% ( -84.76%)
  • Historical Volatility 81.20%
  • IV Percentile 77%
  • IV Rank 20.92%
  • IV High 1,079.45% on 06/10/22
  • IV Low 30.39% on 02/14/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,253
  • Open Int (30-Day) 2,296

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.16
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8200 +8.41%
on 07/05/22
1.3450 -33.90%
on 06/09/22
-0.2110 (-19.18%)
since 06/03/22
3-Month
0.8200 +8.41%
on 07/05/22
1.4600 -39.11%
on 04/06/22
-0.5610 (-38.69%)
since 04/05/22
52-Week
0.8200 +8.41%
on 07/05/22
6.2500 -85.78%
on 07/06/21
-5.0010 (-84.91%)
since 07/02/21

Most Recent Stories

More News
Oncocyte Hosting Key Opinion Webinar on the Role of DetermaIO and the Tumor Microenvironment in Clinical Practice

IRVINE, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), is a precision diagnostics company with the mission to improve...

OCX : 0.8890 (+4.34%)
Oncocyte Presents DetermaIO™ Data at ASCO 2022 Supporting the Test’s Potential to Expand the Clinical Use of Immunotherapy

DetermaIO identifies responders to immunotherapy among the 95% of patients with colon cancer currently ineligible for treatment based on existing...

OCX : 0.8890 (+4.34%)
OncoCyte (OCX) Reports Q1 Loss, Lags Revenue Estimates

OncoCyte (OCX) delivered earnings and revenue surprises of 15.38% and 16.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OCX : 0.8890 (+4.34%)
IONM : 1.4500 (-1.54%)
Tivity Health (TVTY) Q1 Earnings and Revenues Lag Estimates

Tivity Health (TVTY) delivered earnings and revenue surprises of -4.76% and 4.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TVTY : 32.50 (+0.06%)
OCX : 0.8890 (+4.34%)
Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test

Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions ...

OCX : 0.8890 (+4.34%)
Oncocyte to Announce First Quarter 2022 Financial Results

IRVINE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve...

OCX : 0.8890 (+4.34%)
Oncocyte to Present New Data at ASCO 2022 Underpinning Pan-Cancer Clinical Utility of DetermaIO™

Data points to accuracy of IO Score and provides grounds for its further use to evaluate response to immune checkpoint therapies for patients with...

OCX : 0.8890 (+4.34%)
Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today the pricing of an...

OCX : 0.8890 (+4.34%)
Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today that it has...

OCX : 0.8890 (+4.34%)
Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company...

OCX : 0.8890 (+4.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

See More

Key Turning Points

3rd Resistance Point 1.0047
2nd Resistance Point 0.9539
1st Resistance Point 0.9215
Last Price 0.8890
1st Support Level 0.8383
2nd Support Level 0.7875
3rd Support Level 0.7551

See More

52-Week High 6.2500
Fibonacci 61.8% 4.1757
Fibonacci 50% 3.5350
Fibonacci 38.2% 2.8943
Last Price 0.8890
52-Week Low 0.8200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar